Cargando…
Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
In a RCT of 63 patients with COPD, 12 weeks of ICS/LABA therapy downregulated bronchial epithelial expression of the SARS-CoV-2-related genes ACE2 and ADAM17 compared to LABA alone. This may have implications for COVID-19 susceptibility/severity in COPD. https://bit.ly/3vZnBVO
Autores principales: | Milne, Stephen, Li, Xuan, Yang, Chen Xi, Leitao Filho, Fernando Sergio, Hernández Cordero, Ana I., Yang, Cheng Wei Tony, Shaipanich, Tawimas, van Eeden, Stephan F., Leung, Janice M., Lam, Stephen, Sin, Don D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015643/ https://www.ncbi.nlm.nih.gov/pubmed/33795322 http://dx.doi.org/10.1183/13993003.00130-2021 |
Ejemplares similares
-
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020) -
Inhaled Corticosteroids Selectively Alter the Microbiome and Host Transcriptome in the Small Airways of Patients with Chronic Obstructive Pulmonary Disease
por: Yip, William, et al.
Publicado: (2022) -
Airway Eosinophilia on Bronchoalveolar Lavage and the Risk of Exacerbations in COPD
por: Ho, Chunman Germain, et al.
Publicado: (2022) -
Systemic and Airway Epigenetic Disruptions Are Associated with Health Status in COPD
por: Hernandez Cordero, Ana I., et al.
Publicado: (2023) -
Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022)